Purpose

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.

Conditions

Eligibility

Eligible Ages
All ages
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • There is no age limit for the low risk stratum (stage I ovarian immature teratoma and stage I non-seminoma or seminoma malignant GCT [all sites]) - Standard risk 1: Patients must be < 11 years of age at enrollment - Standard risk 2: Patients must be >= 11 and < 25 years of age at enrollment - Patients enrolling on one of the low risk arms must be newly diagnosed with a stage I germ cell tumor; for the standard risk arms, patients must be newly diagnosed with malignant germ cell tumor (stage II or higher). - Histologic confirmation of a primary extracranial germ cell tumor in any of the categories outlined below is required of all patients at enrollment , with the following exceptions: - Among patients were initially diagnosed with completely resected non-seminoma malignant GCT and later recur during observation post surgery, a diagnostic biopsy is not required for enrollment if elevated tumor markers rise to > 5 x upper limit of normal (ULN) on at least 2 measurements taken at least 1 week apart. The pathology report of initial surgery should be provided - Patients may be enrolled without histologic or cytologic confirmation in the rare case where there are exceptionally raised tumor markers (alpha fetoprotein [AFP- ≥ 500 ng/mL or HCG ≥ 500 IU/L) and radiologic features consistent with GCT. In addition, the treating clinician must deem that the patient's tumor is not suitable for upfront resection and that a biopsy is not in the patient's best interest; or that there is a need to start therapy urgently - Low risk immature teratoma (IT); site: ovarian; stage: any; grade: any; histology: pure immature teratoma, mixed immature and mature teratoma, (may contain microscopic foci of yolk sac tumor [< 3 mm], but no other pathological evidence of MGCT); tumor markers: alpha-FP =< 1,000 ng/mL, beta-HCG institutional normal; all ages - Low risk stage I non-seminoma MGCT; site: ovarian, testicular, or extragonadal; stage: COG stage I, FIGO stage IA and IB, American Joint Committee on Cancer (AJCC) testicular stage IA, IB and IS; histology: must contain at least one of the following: yolk sac tumor, embryonal carcinoma, or choriocarcinoma (pure or mixed); all ages - Low risk stage I seminoma-MGCT; site: testicular; stage: COG stage I; AJCC testicular stage IA IB, and IS; histology: must contain only seminoma; may contain immature/mature teratoma; may NOT contain yolk sac tumor, embryonal carcinoma, or choriocarcinoma; all ages - Standard risk 1 (SR1); site: ovarian, testicular, or extragonadal; stage: COG stage II-IV, FIGO stage IC-IV, (International Germ Cell Consensus Classification [IGCCC] criteria DO NOT apply); histology: must contain at least one of the following: yolk sac tumor, embryonal carcinoma, or choriocarcinoma; age (years) < 11 - Standard risk 2 (SR2) - Site: ovarian; stage: COG stage II, III, and III-X, FIGO stage IC, II and III; histology: must contain at least one of the following: yolk sac tumor, embryonal carcinoma, or choriocarcinoma; age (years) >= 11 and < 25 - Site: testicular; stage: COG stage II-IV, AJCC stage II, III, IGCCC good risk; histology: must contain at least one of the following: yolk sac tumor, embryonal carcinoma, or choriocarcinoma: must be IGCCC good risk; post op: alpha-FP < 1,000 ng/mL, beta-HCG < 5,000 IU/mL and lactate dehydrogenase (LDH) < 3.0 x normal; age (years) >= 11 and < 25 - Notes: - IGCCC criteria only apply to SR2 patients with a testicular primary tumor - Use post-op tumor marker levels to determine IGCCC risk group - Pure seminoma patients are not eligible for the standard risk arms of the study - For the low risk stage I non-seminoma MGCT and the standard risk arms, components of yolk sac tumor, embryonal carcinoma, or choriocarcinoma can be mixed with other forms of GCT, such as seminoma or mature or immature teratoma; if yolk sac tumor is the only malignant component present, then it must be deemed by the pathologist to be greater than a "microscopic component" of yolk sac tumor - Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1, 2 or 3; use Karnofsky for patients > 16 years of age and Lansky for patients =< 16 years of age - Organ function requirements apply ONLY to patients who will receive chemotherapy (SR1 and SR2 patients) - Adequate renal function defined as: - Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2 (within 7 days prior to enrollment) OR - A serum creatinine based on age/sex as follows (within 7 days prior to enrollment): (mg/dL) - 1 month to < 6 months male: 0.4 female: 0.4 - 6 months to < 1 year male: 0.5 female: 0.5 - 1 to < 2 years male: 0.6 female: 0.6 - 2 to < 6 years male: 0.8 female: 0.8 - 6 to < 10 years male: 1 female: 1 - 10 to < 13 years male: 1.2 female: 1.2 - 13 to < 16 years: male: 1.5 female: 1.4 - >= 16 years male: 1.7 female: 1.4 - Total bilirubin =< 2 x upper limit of normal (ULN) for age (within 7 days prior to enrollment) - Unless due to Gilbert's disease, malignant involvement of liver or vanishing bile duct syndrome - Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) < 3 x upper limit of normal (ULN) (within 7 days prior to enrollment) - Unless due to Gilbert's disease, malignant involvement of liver or vanishing bile duct syndrome - Peripheral absolute neutrophil count (ANC) >= 750/mm^3 (within 7 days prior to enrollment) AND - Platelet count >= 75,000/mm^3 (within 7 days prior to enrollment) - Patients enrolling on the standard risk arms must be medically fit to receive protocol treatment and with no contraindications to protocol treatment - Eligibility criteria to participate in the pilot study of the AYA-Hears instrument (patient reported outcomes [PROs] of ototoxicity) Note: participants in group 1 will not receive AGCT1531 protocol-directed therapy; all other AYA-HEARS patients must be enrolled on the AGCT1531 SR2 arm in order to participate - >= 11 and < 25 years old at enrollment - Able to fluently speak and read English - Has received prior cisplatin- or carboplatin-based chemotherapy regimen for malignancy including diagnoses other than germ cell tumor - Followed for cancer or survivorship care at one of the following institutions: - Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center - Dana Farber/Harvard Cancer Center - Hospital for Sick Children - Children's Hospital of Eastern Ontario - Oregon Health and Science University - Seattle Children's Hospital - Yale University

Exclusion Criteria

  • Patients with any diagnoses not listed including: - Stage I testicular cancer patients who have undergone primary RPLND (retroperitoneal lymph node dissection) - Pure ovarian or extragonadal dysgerminoma/seminoma - Pure mature teratoma - Pure immature teratoma with alpha-fetoprotein (AFP) >= 1000 ng/mL - "Poor risk" GCT (age >= 11 years old and COG stage IV ovarian, COG stage II- IV extragonadal, or IGCCC intermediate or poor risk testicular), or - Primary central nervous system (CNS) germ cell tumor - Germ cell tumor with somatic malignant transformation - Spermatocytic seminoma - Patients must have had no prior systemic therapy for the current cancer diagnosis - Patients must have had no prior radiation therapy with the exception of CNS irradiation of brain metastases; (this exception only applies to SR1 patients; any patients over age 11 with distant metastases to brain [stage IV disease] would be considered poor risk and therefore not eligible for this trial) - Patients with significant, pre-existing co-morbid respiratory disease that contraindicate the use of bleomycin are ineligible for the standard risk arms of the trial - Female patients who are pregnant since fetal toxicities and teratogenic effects have been noted for several of the study drugs; a pregnancy test is required for female patients of childbearing potential; (this criteria applies ONLY to patients who will receive chemotherapy [SR1 and SR2 patients]) - Lactating females who plan to breastfeed their infants; (this criteria applies ONLY to patients who will receive chemotherapy [SR1 and SR2 patients]) - Sexually active patients of reproductive potential who have not agreed to use an effective contraceptive method for the duration of their study participation; (this criteria applies ONLY to patients who will receive chemotherapy [SR1 and SR2 patients])

Study Design

Phase
Phase 3
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Arm I (bleomycin, carboplatin, etoposide)
Patients receive bleomycin IV over 10 minutes and carboplatin IV over 1 hour on day 1. Patients also receive etoposide IV over 1-2 hours on days 1-5. Treatment repeats every 21 days for up to 4 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT, MRI, and/or chest x-ray as well as blood sample collection throughout the trial. Patients may also undergo a tumor biopsy throughout the trial. Patients undergo a pulmonary function test on study.
  • Procedure: Biopsy Procedure
    Undergo a tumor biopsy
    Other names:
    • Biopsy
    • BIOPSY_TYPE
    • Bx
  • Procedure: Biospecimen Collection
    Undergo blood sample collection
    Other names:
    • Biological Sample Collection
    • Biospecimen Collected
    • Specimen Collection
  • Biological: Bleomycin Sulfate
    Given IV
    Other names:
    • Blanoxan
    • BleMomycine
    • Blenoxane
    • Bleo-cell
    • Bleo-S
    • Bleocin
    • Bleolem
    • Bleomycin Sulfas
    • Bleomycin Sulphate
    • Bleomycini Sulfas
    • Blexane
    • Oil Bleo
  • Drug: Carboplatin
    Given IV
    Other names:
    • Blastocarb
    • Carboplat
    • Carboplatin Hexal
    • Carboplatino
    • Carboplatinum
    • Carbosin
    • Carbosol
    • Carbotec
    • CBDCA
    • Displata
    • Ercar
    • JM-8
    • JM8
    • Nealorin
    • Novoplatinum
    • Paraplatin
    • Paraplatin AQ
    • Paraplatine
    • Platinwas
    • Ribocarbo
  • Procedure: Computed Tomography
    Undergo a CT scan
    Other names:
    • CAT
    • CAT Scan
    • Computed Axial Tomography
    • Computerized Axial Tomography
    • Computerized axial tomography (procedure)
    • Computerized Tomography
    • Computerized Tomography (CT) scan
    • CT
    • CT Scan
    • tomography
  • Drug: Etoposide
    Given IV
    Other names:
    • Demethyl Epipodophyllotoxin Ethylidine Glucoside
    • EPEG
    • Lastet
    • Toposar
    • Vepesid
    • VP 16
    • VP 16-213
    • VP 16213
    • VP-16
    • VP-16-213
    • VP-16213
    • VP16
    • VP16213
  • Procedure: Magnetic Resonance Imaging
    Undergo MRI
    Other names:
    • Magnetic Resonance
    • Magnetic Resonance Imaging (MRI)
    • Magnetic resonance imaging (procedure)
    • Magnetic Resonance Imaging Scan
    • Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance
    • MR
    • MR Imaging
    • MRI
    • MRI Scan
    • MRIs
    • NMR Imaging
    • NMRI
    • Nuclear Magnetic Resonance Imaging
    • sMRI
    • Structural MRI
  • Other: Pharmacogenomic Study
    Correlative studies
    Other names:
    • PHARMACOGENOMIC
  • Procedure: Pulmonary Function Test
    Undergo a pulmonary function test
    Other names:
    • lung function test
    • PFT
    • Pulmonary Function Testing
    • Pulmonary Function Tests
  • Other: Quality-of-Life Assessment
    Ancillary studies
    Other names:
    • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies
Experimental
Arm II (bleomycin, etoposide, cisplatin)
Patients receive bleomycin IV over 10 minutes on day 1. Patients also receive etoposide IV over 1-2 hours and cisplatin IV over 1-3 hours on days 1-5. Treatment repeats every 21 days for up to 4 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT, MRI, and/or chest x-ray as well as blood sample collection throughout the trial. Patients may also undergo a tumor biopsy throughout the trial. Patients undergo a pulmonary function test on study.
  • Procedure: Biopsy Procedure
    Undergo a tumor biopsy
    Other names:
    • Biopsy
    • BIOPSY_TYPE
    • Bx
  • Procedure: Biospecimen Collection
    Undergo blood sample collection
    Other names:
    • Biological Sample Collection
    • Biospecimen Collected
    • Specimen Collection
  • Biological: Bleomycin Sulfate
    Given IV
    Other names:
    • Blanoxan
    • BleMomycine
    • Blenoxane
    • Bleo-cell
    • Bleo-S
    • Bleocin
    • Bleolem
    • Bleomycin Sulfas
    • Bleomycin Sulphate
    • Bleomycini Sulfas
    • Blexane
    • Oil Bleo
  • Drug: Cisplatin
    Given IV
    Other names:
    • Abiplatin
    • Blastolem
    • Briplatin
    • CDDP
    • Cis-diammine-dichloroplatinum
    • Cis-diamminedichloridoplatinum
    • Cis-diamminedichloro Platinum (II)
    • Cis-diamminedichloroplatinum
    • Cis-dichloroammine Platinum (II)
    • Cis-platinous Diamine Dichloride
    • Cis-platinum
    • Cis-platinum II
    • Cis-platinum II Diamine Dichloride
    • Cismaplat
    • Cisplatina
    • Cisplatinum
    • Cisplatyl
    • Citoplatino
    • Citosin
    • Cysplatyna
    • DDP
    • Lederplatin
    • Metaplatin
    • Neoplatin
    • Peyrone's Chloride
    • Peyrone's Salt
    • Placis
    • Plastistil
    • Platamine
    • Platiblastin
    • Platiblastin-S
    • Platinex
    • Platinol
    • Platinol- AQ
    • Platinol-AQ
    • Platinol-AQ VHA Plus
    • Platinoxan
    • Platinum
    • Platinum Diamminodichloride
    • Platiran
    • Platistin
    • Platosin
  • Procedure: Computed Tomography
    Undergo a CT scan
    Other names:
    • CAT
    • CAT Scan
    • Computed Axial Tomography
    • Computerized Axial Tomography
    • Computerized axial tomography (procedure)
    • Computerized Tomography
    • Computerized Tomography (CT) scan
    • CT
    • CT Scan
    • tomography
  • Drug: Etoposide
    Given IV
    Other names:
    • Demethyl Epipodophyllotoxin Ethylidine Glucoside
    • EPEG
    • Lastet
    • Toposar
    • Vepesid
    • VP 16
    • VP 16-213
    • VP 16213
    • VP-16
    • VP-16-213
    • VP-16213
    • VP16
    • VP16213
  • Procedure: Magnetic Resonance Imaging
    Undergo MRI
    Other names:
    • Magnetic Resonance
    • Magnetic Resonance Imaging (MRI)
    • Magnetic resonance imaging (procedure)
    • Magnetic Resonance Imaging Scan
    • Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance
    • MR
    • MR Imaging
    • MRI
    • MRI Scan
    • MRIs
    • NMR Imaging
    • NMRI
    • Nuclear Magnetic Resonance Imaging
    • sMRI
    • Structural MRI
  • Other: Pharmacogenomic Study
    Correlative studies
    Other names:
    • PHARMACOGENOMIC
  • Procedure: Pulmonary Function Test
    Undergo a pulmonary function test
    Other names:
    • lung function test
    • PFT
    • Pulmonary Function Testing
    • Pulmonary Function Tests
  • Other: Quality-of-Life Assessment
    Ancillary studies
    Other names:
    • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies
Experimental
Arm III (bleomycin, etoposide, carboplatin)
Patients receive bleomycin IV over 10 minutes on days 1, 8, and 15, etoposide IV over 1-2 hours on days 1-5, and carboplatin IV over 1 hour on day 1. Treatment repeats every 21 days for up to 3 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT, MRI, and/or chest x-ray as well as blood sample collection throughout the trial. Patients may also undergo a tumor biopsy throughout the trial. Patients undergo a pulmonary function test on study.
  • Procedure: Biopsy Procedure
    Undergo a tumor biopsy
    Other names:
    • Biopsy
    • BIOPSY_TYPE
    • Bx
  • Procedure: Biospecimen Collection
    Undergo blood sample collection
    Other names:
    • Biological Sample Collection
    • Biospecimen Collected
    • Specimen Collection
  • Biological: Bleomycin Sulfate
    Given IV
    Other names:
    • Blanoxan
    • BleMomycine
    • Blenoxane
    • Bleo-cell
    • Bleo-S
    • Bleocin
    • Bleolem
    • Bleomycin Sulfas
    • Bleomycin Sulphate
    • Bleomycini Sulfas
    • Blexane
    • Oil Bleo
  • Drug: Carboplatin
    Given IV
    Other names:
    • Blastocarb
    • Carboplat
    • Carboplatin Hexal
    • Carboplatino
    • Carboplatinum
    • Carbosin
    • Carbosol
    • Carbotec
    • CBDCA
    • Displata
    • Ercar
    • JM-8
    • JM8
    • Nealorin
    • Novoplatinum
    • Paraplatin
    • Paraplatin AQ
    • Paraplatine
    • Platinwas
    • Ribocarbo
  • Procedure: Computed Tomography
    Undergo a CT scan
    Other names:
    • CAT
    • CAT Scan
    • Computed Axial Tomography
    • Computerized Axial Tomography
    • Computerized axial tomography (procedure)
    • Computerized Tomography
    • Computerized Tomography (CT) scan
    • CT
    • CT Scan
    • tomography
  • Drug: Etoposide
    Given IV
    Other names:
    • Demethyl Epipodophyllotoxin Ethylidine Glucoside
    • EPEG
    • Lastet
    • Toposar
    • Vepesid
    • VP 16
    • VP 16-213
    • VP 16213
    • VP-16
    • VP-16-213
    • VP-16213
    • VP16
    • VP16213
  • Procedure: Magnetic Resonance Imaging
    Undergo MRI
    Other names:
    • Magnetic Resonance
    • Magnetic Resonance Imaging (MRI)
    • Magnetic resonance imaging (procedure)
    • Magnetic Resonance Imaging Scan
    • Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance
    • MR
    • MR Imaging
    • MRI
    • MRI Scan
    • MRIs
    • NMR Imaging
    • NMRI
    • Nuclear Magnetic Resonance Imaging
    • sMRI
    • Structural MRI
  • Other: Pharmacogenomic Study
    Correlative studies
    Other names:
    • PHARMACOGENOMIC
  • Procedure: Pulmonary Function Test
    Undergo a pulmonary function test
    Other names:
    • lung function test
    • PFT
    • Pulmonary Function Testing
    • Pulmonary Function Tests
  • Other: Quality-of-Life Assessment
    Ancillary studies
    Other names:
    • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies
Experimental
Arm IV (bleomycin, etoposide, cisplatin)
Patients receive bleomycin IV over 10 minutes on days 1, 8, and 15, etoposide IV over 1-2 hours on days 1-5, and cisplatin IV over 1-3 hours on days 1-5. Treatment repeats every 21 days for up to 3 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT, MRI, and/or chest x-ray as well as blood sample collection throughout the trial. Patients may also undergo a tumor biopsy throughout the trial. Patients undergo a pulmonary function test on study.
  • Procedure: Biopsy Procedure
    Undergo a tumor biopsy
    Other names:
    • Biopsy
    • BIOPSY_TYPE
    • Bx
  • Procedure: Biospecimen Collection
    Undergo blood sample collection
    Other names:
    • Biological Sample Collection
    • Biospecimen Collected
    • Specimen Collection
  • Biological: Bleomycin Sulfate
    Given IV
    Other names:
    • Blanoxan
    • BleMomycine
    • Blenoxane
    • Bleo-cell
    • Bleo-S
    • Bleocin
    • Bleolem
    • Bleomycin Sulfas
    • Bleomycin Sulphate
    • Bleomycini Sulfas
    • Blexane
    • Oil Bleo
  • Drug: Cisplatin
    Given IV
    Other names:
    • Abiplatin
    • Blastolem
    • Briplatin
    • CDDP
    • Cis-diammine-dichloroplatinum
    • Cis-diamminedichloridoplatinum
    • Cis-diamminedichloro Platinum (II)
    • Cis-diamminedichloroplatinum
    • Cis-dichloroammine Platinum (II)
    • Cis-platinous Diamine Dichloride
    • Cis-platinum
    • Cis-platinum II
    • Cis-platinum II Diamine Dichloride
    • Cismaplat
    • Cisplatina
    • Cisplatinum
    • Cisplatyl
    • Citoplatino
    • Citosin
    • Cysplatyna
    • DDP
    • Lederplatin
    • Metaplatin
    • Neoplatin
    • Peyrone's Chloride
    • Peyrone's Salt
    • Placis
    • Plastistil
    • Platamine
    • Platiblastin
    • Platiblastin-S
    • Platinex
    • Platinol
    • Platinol- AQ
    • Platinol-AQ
    • Platinol-AQ VHA Plus
    • Platinoxan
    • Platinum
    • Platinum Diamminodichloride
    • Platiran
    • Platistin
    • Platosin
  • Procedure: Computed Tomography
    Undergo a CT scan
    Other names:
    • CAT
    • CAT Scan
    • Computed Axial Tomography
    • Computerized Axial Tomography
    • Computerized axial tomography (procedure)
    • Computerized Tomography
    • Computerized Tomography (CT) scan
    • CT
    • CT Scan
    • tomography
  • Drug: Etoposide
    Given IV
    Other names:
    • Demethyl Epipodophyllotoxin Ethylidine Glucoside
    • EPEG
    • Lastet
    • Toposar
    • Vepesid
    • VP 16
    • VP 16-213
    • VP 16213
    • VP-16
    • VP-16-213
    • VP-16213
    • VP16
    • VP16213
  • Procedure: Magnetic Resonance Imaging
    Undergo MRI
    Other names:
    • Magnetic Resonance
    • Magnetic Resonance Imaging (MRI)
    • Magnetic resonance imaging (procedure)
    • Magnetic Resonance Imaging Scan
    • Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance
    • MR
    • MR Imaging
    • MRI
    • MRI Scan
    • MRIs
    • NMR Imaging
    • NMRI
    • Nuclear Magnetic Resonance Imaging
    • sMRI
    • Structural MRI
  • Other: Pharmacogenomic Study
    Correlative studies
    Other names:
    • PHARMACOGENOMIC
  • Procedure: Pulmonary Function Test
    Undergo a pulmonary function test
    Other names:
    • lung function test
    • PFT
    • Pulmonary Function Testing
    • Pulmonary Function Tests
  • Other: Quality-of-Life Assessment
    Ancillary studies
    Other names:
    • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies
Experimental
Low-Risk (observation)
Patients with low-risk stage I grade 2, 3 ovarian immature teratoma or stage I non-seminoma or seminoma MGCTs undergo observation and can transfer to standard risk arm when eligibility criteria are met. Patients with stage I seminoma testicular MGCT undergo observation, and those with residual/recurrent disease are treated at the discretion of their physician. Patients undergo CT, MRI, and/or chest x-ray as well as blood sample collection throughout the trial. Patients may also undergo a tumor biopsy throughout the trial.
  • Other: Best Practice
    Undergo observation
    Other names:
    • standard of care
    • standard therapy
  • Procedure: Biopsy Procedure
    Undergo a tumor biopsy
    Other names:
    • Biopsy
    • BIOPSY_TYPE
    • Bx
  • Procedure: Biospecimen Collection
    Undergo blood sample collection
    Other names:
    • Biological Sample Collection
    • Biospecimen Collected
    • Specimen Collection
  • Procedure: Computed Tomography
    Undergo a CT scan
    Other names:
    • CAT
    • CAT Scan
    • Computed Axial Tomography
    • Computerized Axial Tomography
    • Computerized axial tomography (procedure)
    • Computerized Tomography
    • Computerized Tomography (CT) scan
    • CT
    • CT Scan
    • tomography
  • Procedure: Magnetic Resonance Imaging
    Undergo MRI
    Other names:
    • Magnetic Resonance
    • Magnetic Resonance Imaging (MRI)
    • Magnetic resonance imaging (procedure)
    • Magnetic Resonance Imaging Scan
    • Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance
    • MR
    • MR Imaging
    • MRI
    • MRI Scan
    • MRIs
    • NMR Imaging
    • NMRI
    • Nuclear Magnetic Resonance Imaging
    • sMRI
    • Structural MRI
  • Other: Pharmacogenomic Study
    Correlative studies
    Other names:
    • PHARMACOGENOMIC
  • Other: Quality-of-Life Assessment
    Ancillary studies
    Other names:
    • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies

Recruiting Locations

Children's Hospital of Alabama
Birmingham 4049979, Alabama 4829764 35233
Contact:
Site Public Contact
205-638-9285
oncologyresearch@peds.uab.edu

USA Health Strada Patient Care Center
Mobile 4076598, Alabama 4829764 36604
Contact:
Site Public Contact
800-388-8721

Anchorage Associates in Radiation Medicine
Anchorage 5879400, Alaska 5879092 98508
Contact:
Site Public Contact
907-212-6871
AKPAMC.OncologyResearchSupport@providence.org

Alaska Breast Care and Surgery LLC
Anchorage 5879400, Alaska 5879092 99508
Contact:
Site Public Contact
907-212-6871
AKPAMC.OncologyResearchSupport@providence.org

Alaska Oncology and Hematology LLC
Anchorage 5879400, Alaska 5879092 99508
Contact:
Site Public Contact
907-212-6871
AKPAMC.OncologyResearchSupport@providence.org

Alaska Women's Cancer Care
Anchorage 5879400, Alaska 5879092 99508
Contact:
Site Public Contact
907-212-6871
AKPAMC.OncologyResearchSupport@providence.org

Katmai Oncology Group
Anchorage 5879400, Alaska 5879092 99508
Contact:
Site Public Contact
907-212-6871
AKPAMC.OncologyResearchSupport@providence.org

Providence Alaska Medical Center
Anchorage 5879400, Alaska 5879092 99508
Contact:
Site Public Contact
907-212-6871
AKPAMC.OncologyResearchSupport@providence.org

Kingman Regional Medical Center
Kingman 5301067, Arizona 5551752 86401
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Banner Children's at Desert
Mesa 5304391, Arizona 5551752 85202
Contact:
Site Public Contact
480-412-3100

Phoenix Childrens Hospital
Phoenix 5308655, Arizona 5551752 85016
Contact:
Site Public Contact
602-546-0920

Arkansas Children's Hospital
Little Rock 4119403, Arkansas 4099753 72202-3591
Contact:
Site Public Contact
501-364-7373

CARTI Cancer Center
Little Rock 4119403, Arkansas 4099753 72205
Contact:
Site Public Contact
501-906-4199
Research@CARTI.com

Kaiser Permanente-Anaheim
Anaheim 5323810, California 5332921 92806
Contact:
Site Public Contact
800-398-3996
clinical.trials@kp.org

PCR Oncology
Arroyo Grande 5324802, California 5332921 93420
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Kaiser Permanente-Bellflower
Bellflower 5327422, California 5332921 90706
Contact:
Site Public Contact
800-398-3996
clinical.trials@kp.org

Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank 5331835, California 5332921 91505
Contact:
Site Public Contact
818-847-4793
Najee.Boucher@providence.org

Kaiser Permanente Downey Medical Center
Downey 5343858, California 5332921 90242
Contact:
Site Public Contact
626-564-3455

Kaiser Permanente-Fontana
Fontana 5349755, California 5332921 92335
Contact:
Site Public Contact
800-398-3996
clinical.trials@kp.org

UC San Diego Moores Cancer Center
La Jolla 5363943, California 5332921 92093
Contact:
Site Public Contact
858-822-5354
cancercto@ucsd.edu

Loma Linda University Medical Center
Loma Linda 5367696, California 5332921 92354
Contact:
Site Public Contact
909-558-4050

Miller Children's and Women's Hospital Long Beach
Long Beach 5367929, California 5332921 90806
Contact:
Site Public Contact
562-933-5600

Children's Hospital Los Angeles
Los Angeles 5368361, California 5332921 90027
Contact:
Site Public Contact
323-361-4110

Kaiser Permanente Los Angeles Medical Center
Los Angeles 5368361, California 5332921 90027
Contact:
Site Public Contact
800-398-3996
clinical.trials@kp.org

Cedars Sinai Medical Center
Los Angeles 5368361, California 5332921 90048
Contact:
Site Public Contact
310-423-8965

Mattel Children's Hospital UCLA
Los Angeles 5368361, California 5332921 90095
Contact:
Site Public Contact
310-825-6708

Valley Children's Hospital
Madera 5369568, California 5332921 93636
Contact:
Site Public Contact
559-353-3000
Research@valleychildrens.org

Providence Queen of The Valley
Napa 5376095, California 5332921 94558
Contact:
Site Public Contact
707-521-3830

UCSF Benioff Children's Hospital Oakland
Oakland 5378538, California 5332921 94609
Contact:
Site Public Contact
510-428-3264
cogbchoak@ucsf.edu

Kaiser Permanente-Oakland
Oakland 5378538, California 5332921 94611
Contact:
Site Public Contact
877-642-4691
Kpoct@kp.org

Children's Hospital of Orange County
Orange 5379513, California 5332921 92868
Contact:
Site Public Contact
714-509-8646
oncresearch@choc.org

Lucile Packard Children's Hospital Stanford University
Palo Alto 5380748, California 5332921 94304
Contact:
Site Public Contact
800-694-0012
ccto-office@stanford.edu

University of California Davis Comprehensive Cancer Center
Sacramento 5389489, California 5332921 95817
Contact:
Site Public Contact
916-734-3089

Kaiser Permanente-San Diego Mission
San Diego 5391811, California 5332921 92108
Contact:
Site Public Contact
800-398-3996
clinical.trials@kp.org

Rady Children's Hospital - San Diego
San Diego 5391811, California 5332921 92123
Contact:
Site Public Contact
858-966-5934

Naval Medical Center -San Diego
San Diego 5391811, California 5332921 92134
Contact:
Site Public Contact
619-532-8712

UCSF Medical Center-Mission Bay
San Francisco 5391959, California 5332921 94158
Contact:
Site Public Contact
877-827-3222
cancertrials@ucsf.edu

Providence Medical Foundation - Santa Rosa
Santa Rosa 5393287, California 5332921 95403
Contact:
Site Public Contact
707-521-3830

Providence Santa Rosa Memorial Hospital
Santa Rosa 5393287, California 5332921 95405
Contact:
Site Public Contact
707-521-3830

Children's Hospital Colorado
Aurora 5412347, Colorado 5417618 80045
Contact:
Site Public Contact
303-764-5056
josh.b.gordon@nsmtp.kp.org

Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
Denver 5419384, Colorado 5417618 80218
Contact:
Site Public Contact
303-832-2344
PSGResearchSharedMailbox@HCAHealthcare.com

Connecticut Children's Medical Center
Hartford 4835797, Connecticut 4831725 06106
Contact:
Site Public Contact
860-545-9981

Yale University
New Haven 4839366, Connecticut 4831725 06520
Contact:
Site Public Contact
203-785-5702
canceranswers@yale.edu

Alfred I duPont Hospital for Children
Wilmington 4145381, Delaware 4142224 19803
Contact:
Site Public Contact
302-651-5572
Allison.bruce@nemours.org

Children's National Medical Center
Washington D.C. 4140963, District of Columbia 4138106 20010
Contact:
Site Public Contact
202-476-2800
OncCRC_OnCall@childrensnational.org

Broward Health Medical Center
Fort Lauderdale 4155966, Florida 4155751 33316
Contact:
Site Public Contact
302-651-5572
Allison.bruce@nemours.org

Golisano Children's Hospital of Southwest Florida
Fort Myers 4155995, Florida 4155751 33908
Contact:
Site Public Contact
239-343-5333
molly.arnstrom@leehealth.org

University of Florida Health Science Center - Gainesville
Gainesville 4156404, Florida 4155751 32610
Contact:
Site Public Contact
352-273-8010
cancer-center@ufl.edu

Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Hollywood 4158928, Florida 4155751 33021
Contact:
Site Public Contact
954-265-1847
OHR@mhs.net

Nemours Children's Clinic-Jacksonville
Jacksonville 4160021, Florida 4155751 32207
Contact:
Site Public Contact
302-651-5572
Allison.bruce@nemours.org

University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami 4164138, Florida 4155751 33136
Contact:
Site Public Contact
305-243-2647

Nicklaus Children's Hospital
Miami 4164138, Florida 4155751 33155
Contact:
Site Public Contact
888-624-2778

Miami Cancer Institute
Miami 4164138, Florida 4155751 33176
Contact:
Site Public Contact
786-596-2000

AdventHealth Orlando
Orlando 4167147, Florida 4155751 32803
Contact:
Site Public Contact
407-303-2090
FH.Cancer.Research@flhosp.org

Arnold Palmer Hospital for Children
Orlando 4167147, Florida 4155751 32806
Contact:
Site Public Contact
321-841-5357
Jennifer.spinelli@orlandohealth.com

Nemours Children's Hospital
Orlando 4167147, Florida 4155751 32827
Contact:
Site Public Contact
302-651-5572
Allison.bruce@nemours.org

Nemours Children's Clinic - Pensacola
Pensacola 4168228, Florida 4155751 32504
Contact:
Site Public Contact
helpdesk@childrensoncologygroup.org

Johns Hopkins All Children's Hospital
St. Petersburg 4171563, Florida 4155751 33701
Contact:
Site Public Contact
727-767-4784
Ashley.Repp@jhmi.edu

Tampa General Hospital
Tampa 4174757, Florida 4155751 33606
Contact:
Site Public Contact
813-844-7829
syapchanyk@tgh.org

Saint Joseph's Hospital/Children's Hospital-Tampa
Tampa 4174757, Florida 4155751 33607
Contact:
Site Public Contact
813-357-0849
jennifer.manns@baycare.org

Saint Mary's Medical Center
West Palm Beach 4177887, Florida 4155751 33407
Contact:
Site Public Contact
561-822-4745

Children's Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta 4180439, Georgia 4197000 30329
Contact:
Site Public Contact
404-785-0232
Olivia.Floyd@choa.org

Augusta University Medical Center
Augusta 4180531, Georgia 4197000 30912
Contact:
Site Public Contact
706-721-2388
ga_cares@augusta.edu

Atrium Health Navicent
Macon 4207400, Georgia 4197000 31201
Contact:
Site Public Contact
478-633-2152
andrew.weatherall@atriumhealth.org

Memorial Health University Medical Center
Savannah 4221552, Georgia 4197000 31404
Contact:
Site Public Contact
912-350-7887
Lorraine.OHara@hcahealthcare.com

Straub Clinic and Hospital
Honolulu 5856195, Hawaii 5855797 96813
Contact:
Site Public Contact
808-522-4333

Kapiolani Medical Center for Women and Children
Honolulu 5856195, Hawaii 5855797 96826
Contact:
Site Public Contact
808-983-6090

Saint Luke's Cancer Institute - Boise
Boise 5586437, Idaho 5596512 83712
Contact:
Site Public Contact
208-381-2774
eslinget@slhs.org

Saint Luke's Cancer Institute - Fruitland
Fruitland 5593708, Idaho 5596512 83619
Contact:
Site Public Contact
208-381-2774
eslinget@slhs.org

Saint Luke's Cancer Institute - Meridian
Meridian 5600685, Idaho 5596512 83642
Contact:
Site Public Contact
208-381-2774
eslinget@slhs.org

Saint Luke's Cancer Institute - Nampa
Nampa 5601933, Idaho 5596512 83687
Contact:
Site Public Contact
208-381-2774
eslinget@slhs.org

Saint Luke's Cancer Institute - Twin Falls
Twin Falls 5610810, Idaho 5596512 83301
Contact:
Site Public Contact
208-381-2774
eslinget@slhs.org

Illinois CancerCare-Bloomington
Bloomington 4885164, Illinois 4896861 61704
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

Illinois CancerCare-Canton
Canton 4831990, Illinois 4896861 61520
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

Memorial Hospital of Carbondale
Carbondale 4235193, Illinois 4896861 62902
Contact:
Site Public Contact
618-457-5200
clinical.research@sih.net

SIH Cancer Institute
Carterville 4235311, Illinois 4896861 62918
Contact:
Site Public Contact
618-985-3333
clinical.research@sih.net

Illinois CancerCare-Carthage
Carthage 4886716, Illinois 4896861 62321
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

Centralia Oncology Clinic
Centralia 4235587, Illinois 4896861 62801
Contact:
Site Public Contact
217-876-4762
morganthaler.jodi@mhsil.com

Lurie Children's Hospital-Chicago
Chicago 4887398, Illinois 4896861 60611
Contact:
Site Public Contact
773-880-4562

University of Illinois
Chicago 4887398, Illinois 4896861 60612
Contact:
Site Public Contact
312-355-3046

University of Chicago Comprehensive Cancer Center
Chicago 4887398, Illinois 4896861 60637
Contact:
Site Public Contact
773-702-8222
cancerclinicaltrials@bsd.uchicago.edu

Cancer Care Specialists of Illinois - Decatur
Decatur 4236895, Illinois 4896861 62526
Contact:
Site Public Contact
217-876-4762
morganthaler.jodi@mhsil.com

Decatur Memorial Hospital
Decatur 4236895, Illinois 4896861 62526
Contact:
Site Public Contact
217-876-4762
morganthaler.jodi@mhsil.com

Illinois CancerCare-Dixon
Dixon 4889959, Illinois 4896861 61021
Contact:
Site Public Contact
815-285-7800

Crossroads Cancer Center
Effingham 4237727, Illinois 4896861 62401
Contact:
Site Public Contact
217-876-4762
morganthaler.jodi@mhsil.com

Illinois CancerCare-Eureka
Eureka 4891310, Illinois 4896861 61530
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

NorthShore University HealthSystem-Evanston Hospital
Evanston 4891382, Illinois 4896861 60201
Contact:
Site Public Contact
847-570-2109

Illinois CancerCare-Galesburg
Galesburg 4893392, Illinois 4896861 61401
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

NorthShore University HealthSystem-Glenbrook Hospital
Glenview 4893886, Illinois 4896861 60026
Contact:
Site Public Contact
847-570-2109

NorthShore University HealthSystem-Highland Park Hospital
Highland Park 4895876, Illinois 4896861 60035
Contact:
Site Public Contact
847-570-2109

Illinois CancerCare-Kewanee Clinic
Kewanee 4898433, Illinois 4896861 61443
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

Illinois CancerCare-Macomb
Macomb 4900817, Illinois 4896861 61455
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

HSHS Saint Elizabeth's Hospital
O'Fallon 4245926, Illinois 4896861 62269
Contact:
Site Public Contact
217-876-4762
morganthaler.jodi@mhsil.com

Advocate Children's Hospital-Oak Lawn
Oak Lawn 4904365, Illinois 4896861 60453
Contact:
Site Public Contact
847-723-7570

Illinois CancerCare-Ottawa Clinic
Ottawa 4905006, Illinois 4896861 61350
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

Advocate Children's Hospital-Park Ridge
Park Ridge 4905367, Illinois 4896861 60068
Contact:
Site Public Contact
helpdesk@childrensoncologygroup.org

Illinois CancerCare-Pekin
Pekin 4905599, Illinois 4896861 61554
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

OSF Saint Francis Radiation Oncology at Pekin
Pekin 4905599, Illinois 4896861 61554
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

Illinois CancerCare-Peoria
Peoria 4905687, Illinois 4896861 61615
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

OSF Saint Francis Radiation Oncology at Peoria Cancer Center
Peoria 4905687, Illinois 4896861 61615
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

Methodist Medical Center of Illinois
Peoria 4905687, Illinois 4896861 61636
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

Saint Jude Midwest Affiliate
Peoria 4905687, Illinois 4896861 61637
Contact:
Site Public Contact
888-226-4343

Illinois CancerCare-Peru
Peru 4905770, Illinois 4896861 61354
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

Valley Radiation Oncology
Peru 4905770, Illinois 4896861 61354
Contact:
Site Public Contact
815-664-4141

Illinois CancerCare-Princeton
Princeton 4906818, Illinois 4896861 61356
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

Saint John's Hospital
Springfield 4250542, Illinois 4896861 62702
Contact:
Site Public Contact
217-525-5666
diana.weyhenmeyer@st-johns.org

Southern Illinois University School of Medicine
Springfield 4250542, Illinois 4896861 62702
Contact:
Site Public Contact
217-545-7929

Springfield Clinic
Springfield 4250542, Illinois 4896861 62702
Contact:
Site Public Contact
800-444-7541

Illinois CancerCare - Washington
Washington 4915545, Illinois 4896861 61571
Contact:
Site Public Contact
309-243-3605
andersonj@illinoiscancercare.com

Riley Hospital for Children
Indianapolis 4259418, Indiana 4921868 46202
Contact:
Site Public Contact
800-248-1199

Ascension Saint Vincent Indianapolis Hospital
Indianapolis 4259418, Indiana 4921868 46260
Contact:
Site Public Contact
317-338-2194
research@stvincent.org

Mercy Cancer Center-West Lakes
Clive 4852065, Iowa 4862182 50325
Contact:
Site Public Contact
515-358-6613
cancerresearch@mercydesmoines.org

Greater Regional Medical Center
Creston 4853078, Iowa 4862182 50801
Contact:
Site Public Contact
515-358-6613
cancerresearch@mercydesmoines.org

Blank Children's Hospital
Des Moines 4853828, Iowa 4862182 50309
Contact:
Site Public Contact
515-241-8912
samantha.mallory@unitypoint.org

Mercy Medical Center - Des Moines
Des Moines 4853828, Iowa 4862182 50314
Contact:
Site Public Contact
515-358-6613
cancerresearch@mercydesmoines.org

University of Iowa/Holden Comprehensive Cancer Center
Iowa City 4862034, Iowa 4862182 52242
Contact:
Site Public Contact
800-237-1225

Mercy Medical Center-West Lakes
West Des Moines 4881346, Iowa 4862182 50266
Contact:
Site Public Contact
515-358-6613
cancerresearch@mercydesmoines.org

Wesley Medical Center
Wichita 4281730, Kansas 4273857 67214
Contact:
Site Public Contact
316-962-7802
WesleyResearch@wesleymc.com

University of Kentucky/Markey Cancer Center
Lexington 4297983, Kentucky 6254925 40536
Contact:
Site Public Contact
859-257-3379

Norton Children's Hospital
Louisville 4299276, Kentucky 6254925 40202
Contact:
Site Public Contact
502-629-5500
CancerResource@nortonhealthcare.org

Children's Hospital New Orleans
New Orleans 4335045, Louisiana 4331987 70118
Contact:
Site Public Contact
504-894-5377

Ochsner Medical Center Jefferson
New Orleans 4335045, Louisiana 4331987 70121
Contact:
Site Public Contact
504-842-8084
Elisemarie.curry@ochsner.org

Eastern Maine Medical Center
Bangor 4957280, Maine 4971068 04401
Contact:
Site Public Contact
207-973-4274

MaineHealth Maine Medical Center - Portland
Portland 4975802, Maine 4971068 04102
Contact:
Site Public Contact
207-396-8670
clinicalresearch@mainehealth.org

Maine Children's Cancer Program
Scarborough 4977882, Maine 4971068 04074
Contact:
Site Public Contact
207-396-8670
clinicalresearch@mainehealth.org

MaineHealth Maine Medical Center- Scarborough
Scarborough 4977882, Maine 4971068 04074
Contact:
Site Public Contact
207-396-8670
clinicalresearch@mainehealth.org

University of Maryland/Greenebaum Cancer Center
Baltimore 4347778, Maryland 4361885 21201
Contact:
Site Public Contact
800-888-8823

Sinai Hospital of Baltimore
Baltimore 4347778, Maryland 4361885 21215
Contact:
Site Public Contact
410-601-9083

Johns Hopkins University/Sidney Kimmel Cancer Center
Baltimore 4347778, Maryland 4361885 21287
Contact:
Site Public Contact
410-955-8804
jhcccro@jhmi.edu

Walter Reed National Military Medical Center
Bethesda 4348599, Maryland 4361885 20889-5600
Contact:
Site Public Contact
301-319-2100

Tufts Medical Center
Boston 4930956, Massachusetts 6254926 02111
Contact:
Site Public Contact
617-636-5000
ContactUsCancerCenter@TuftsMedicalCenter.org

Massachusetts General Hospital Cancer Center
Boston 4930956, Massachusetts 6254926 02114
Contact:
Site Public Contact
877-726-5130

Dana-Farber Cancer Institute
Boston 4930956, Massachusetts 6254926 02215
Contact:
Site Public Contact
877-442-3324

Baystate Medical Center
Springfield 4951788, Massachusetts 6254926 01199
Contact:
Site Public Contact
413-794-3565
tamara.wrenn@baystatehealth.org

UMass Memorial Medical Center - University Campus
Worcester 4956184, Massachusetts 6254926 01655
Contact:
Site Public Contact
508-856-3216
cancer.research@umassmed.edu

C S Mott Children's Hospital
Ann Arbor 4984247, Michigan 5001836 48109
Contact:
Site Public Contact
800-865-1125

University of Michigan Comprehensive Cancer Center
Ann Arbor 4984247, Michigan 5001836 48109
Contact:
Site Public Contact
slusserb@med.umich.edu

Bronson Battle Creek
Battle Creek 4985153, Michigan 5001836 49017
Contact:
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Children's Hospital of Michigan
Detroit 4990729, Michigan 5001836 48201
Contact:
Site Public Contact
helpdesk@childrensoncologygroup.org

Corewell Health Grand Rapids Hospitals - Butterworth Hospital
Grand Rapids 4994358, Michigan 5001836 49503
Contact:
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
Grand Rapids 4994358, Michigan 5001836 49503
Contact:
Site Public Contact
616-267-1925
crcwm-regulatory@crcwm.org

Trinity Health Grand Rapids Hospital
Grand Rapids 4994358, Michigan 5001836 49503
Contact:
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Bronson Methodist Hospital
Kalamazoo 4997787, Michigan 5001836 49007
Contact:
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

West Michigan Cancer Center
Kalamazoo 4997787, Michigan 5001836 49007
Contact:
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Beacon Kalamazoo
Kalamazoo 4997787, Michigan 5001836 49048
Contact:
Site Public Contact
574-647-7370

Trinity Health Muskegon Hospital
Muskegon 5003132, Michigan 5001836 49444
Contact:
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Corewell Health Lakeland Hospitals - Niles Hospital
Niles 5003514, Michigan 5001836 49120
Contact:
Site Public Contact
616-391-1230

Corewell Health Reed City Hospital
Reed City 5006946, Michigan 5001836 49677
Contact:
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Corewell Health Children's
Royal Oak 5007804, Michigan 5001836 48073
Contact:
Site Public Contact
248-551-7695

Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
Saint Joseph 5008327, Michigan 5001836 49085
Contact:
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Corewell Health Lakeland Hospitals - Saint Joseph Hospital
Saint Joseph 5008327, Michigan 5001836 49085
Contact:
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Munson Medical Center
Traverse City 5012495, Michigan 5001836 49684
Contact:
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

University of Michigan Health - West
Wyoming 5015618, Michigan 5001836 49519
Contact:
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Children's Hospitals and Clinics of Minnesota - Minneapolis
Minneapolis 5037649, Minnesota 5037779 55404
Contact:
Site Public Contact
612-813-5913
pauline.mitby@childrensmn.org

University of Minnesota/Masonic Cancer Center
Minneapolis 5037649, Minnesota 5037779 55455
Contact:
Site Public Contact
612-624-2620

Mayo Clinic in Rochester
Rochester 5043473, Minnesota 5037779 55905
Contact:
Site Public Contact
855-776-0015

University of Mississippi Medical Center
Jackson 4431410, Mississippi 4436296 39216
Contact:
Site Public Contact
601-815-6700

Mercy Cancer Center - Cape Girardeau
Cape Girardeau 4379966, Missouri 4398678 63703
Contact:
Site Public Contact
888-446-3729

Saint Francis Medical Center
Cape Girardeau 4379966, Missouri 4398678 63703
Contact:
Site Public Contact
573-334-2230
sfmc@sfmc.net

University of Missouri Children's Hospital
Columbia 4381982, Missouri 4398678 65212
Contact:
Site Public Contact
573-882-1960
snwq62@health.missouri.edu

Parkland Health Center - Farmington
Farmington 4386289, Missouri 4398678 63640
Contact:
Site Public Contact
314-996-5569

Children's Mercy Hospitals and Clinics
Kansas City 4393217, Missouri 4398678 64108
Contact:
Site Public Contact
816-302-6808
rryan@cmh.edu

Lake Regional Hospital
Osage Beach 4402040, Missouri 4398678 65065
Contact:
Site Public Contact
573-302-2768
clinicaltrials@lakeregional.com

Sainte Genevieve County Memorial Hospital
Sainte Genevieve 4407294, Missouri 4398678 63670
Contact:
Site Public Contact
314-996-5569

Washington University School of Medicine
St Louis 4407066, Missouri 4398678 63110
Contact:
Site Public Contact
800-600-3606
info@siteman.wustl.edu

Missouri Baptist Medical Center
St Louis 4407066, Missouri 4398678 63131
Contact:
Site Public Contact
314-996-5569

Mercy Hospital Saint Louis
St Louis 4407066, Missouri 4398678 63141
Contact:
Site Public Contact
314-251-7066

Missouri Baptist Sullivan Hospital
Sullivan 4410669, Missouri 4398678 63080
Contact:
Site Public Contact
314-996-5569

BJC Outpatient Center at Sunset Hills
Sunset Hills 4410836, Missouri 4398678 63127
Contact:
Site Public Contact
314-996-5569

Saint Patrick Hospital - Community Hospital
Missoula 5666639, Montana 5667009 59802
Contact:
Site Public Contact
406-327-3118
amy.hanneman@providence.org

Children's Hospital and Medical Center of Omaha
Omaha 5074472, Nebraska 5073708 68114
Contact:
Site Public Contact
402-955-3949

University of Nebraska Medical Center
Omaha 5074472, Nebraska 5073708 68198
Contact:
Site Public Contact
402-559-6941
unmcrsa@unmc.edu

Carson Tahoe Regional Medical Center
Carson City 5501344, Nevada 5509151 89703
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Comprehensive Cancer Centers of Nevada - Henderson
Henderson 5505411, Nevada 5509151 89052
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Comprehensive Cancer Centers of Nevada-Horizon Ridge
Henderson 5505411, Nevada 5509151 89052
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

OptumCare Cancer Care at Seven Hills
Henderson 5505411, Nevada 5509151 89052
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Comprehensive Cancer Centers of Nevada-Southeast Henderson
Henderson 5505411, Nevada 5509151 89074
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Las Vegas Urology - Green Valley
Henderson 5505411, Nevada 5509151 89074
Contact:
Site Public Contact
research@sncrf.org

Las Vegas Urology - Pebble
Henderson 5505411, Nevada 5509151 89074
Contact:
Site Public Contact
research@sncrf.org

Urology Specialists of Nevada - Green Valley
Henderson 5505411, Nevada 5509151 89074
Contact:
Site Public Contact
research@sncrf.org

Las Vegas Urology - Pecos
Las Vegas 5506956, Nevada 5509151 89074
Contact:
Site Public Contact
research@sncrf.org

OptumCare Cancer Care at Charleston
Las Vegas 5506956, Nevada 5509151 89102
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

University Medical Center of Southern Nevada
Las Vegas 5506956, Nevada 5509151 89102
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Hope Cancer Care of Nevada
Las Vegas 5506956, Nevada 5509151 89103
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Radiation Oncology Centers of Nevada Central
Las Vegas 5506956, Nevada 5509151 89106
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Urology Specialists of Nevada - Central
Las Vegas 5506956, Nevada 5509151 89106
Contact:
Site Public Contact
research@sncrf.org

Women's Cancer Center of Nevada
Las Vegas 5506956, Nevada 5509151 89106
Contact:
Site Public Contact
702-851-4672

Sunrise Hospital and Medical Center
Las Vegas 5506956, Nevada 5509151 89109
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Las Vegas Urology - Sunset
Las Vegas 5506956, Nevada 5509151 89113
Contact:
Site Public Contact
research@sncrf.org

Urology Specialists of Nevada - Southwest
Las Vegas 5506956, Nevada 5509151 89113
Contact:
Site Public Contact
research@sncrf.org

Radiation Oncology Centers of Nevada Southeast
Las Vegas 5506956, Nevada 5509151 89119
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Ann M Wierman MD LTD
Las Vegas 5506956, Nevada 5509151 89128
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Comprehensive Cancer Centers of Nevada - Northwest
Las Vegas 5506956, Nevada 5509151 89128
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Las Vegas Urology - Cathedral Rock
Las Vegas 5506956, Nevada 5509151 89128
Contact:
Site Public Contact
research@sncrf.org

Las Vegas Urology - Smoke Ranch
Las Vegas 5506956, Nevada 5509151 89128
Contact:
Site Public Contact
research@smcrf.org

OptumCare Cancer Care at MountainView
Las Vegas 5506956, Nevada 5509151 89128
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Urology Specialists of Nevada - Northwest
Las Vegas 5506956, Nevada 5509151 89128
Contact:
Site Public Contact
research@sncrf.org

Alliance for Childhood Diseases/Cure 4 the Kids Foundation
Las Vegas 5506956, Nevada 5509151 89135
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Comprehensive Cancer Centers of Nevada - Town Center
Las Vegas 5506956, Nevada 5509151 89144
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Comprehensive Cancer Centers of Nevada-Summerlin
Las Vegas 5506956, Nevada 5509151 89144
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Summerlin Hospital Medical Center
Las Vegas 5506956, Nevada 5509151 89144
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Comprehensive Cancer Centers of Nevada
Las Vegas 5506956, Nevada 5509151 89148
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

OptumCare Cancer Care at Fort Apache
Las Vegas 5506956, Nevada 5509151 89148
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Comprehensive Cancer Centers of Nevada - Central Valley
Las Vegas 5506956, Nevada 5509151 89169
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Hope Cancer Care of Nevada-Pahrump
Pahrump 5509851, Nevada 5509151 89048
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Renown Regional Medical Center
Reno 5511077, Nevada 5509151 89502
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Saint Mary's Regional Medical Center
Reno 5511077, Nevada 5509151 89503
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Radiation Oncology Associates
Reno 5511077, Nevada 5509151 89509
Contact:
Site Public Contact
702-384-0013
research@sncrf.org

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
Lebanon 5088597, New Hampshire 5090174 03756
Contact:
Site Public Contact
800-639-6918
cancer.research.nurse@dartmouth.edu

Hackensack University Medical Center
Hackensack 5098706, New Jersey 5101760 07601
Contact:
Site Public Contact
551-996-2897

Morristown Medical Center
Morristown 5101427, New Jersey 5101760 07960
Contact:
Site Public Contact
973-971-5900

Jersey Shore Medical Center
Neptune City 5101687, New Jersey 5101760 07753
Contact:
Site Public Contact
732-776-4240

Saint Peter's University Hospital
New Brunswick 5101717, New Jersey 5101760 08901
Contact:
Site Public Contact
732-745-8600
kcovert@saintpetersuh.com

Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital
New Brunswick 5101717, New Jersey 5101760 08903
Contact:
Site Public Contact
732-235-8675

Newark Beth Israel Medical Center
Newark 5101798, New Jersey 5101760 07112
Contact:
Site Public Contact
973-926-7230
Christine.Kosmides@rwjbh.org

Saint Joseph's Regional Medical Center
Paterson 5102466, New Jersey 5101760 07503
Contact:
Site Public Contact
973-754-2207
HallL@sjhmc.org

Presbyterian Hospital
Albuquerque 5454711, New Mexico 5481136 87106
Contact:
Site Public Contact
505-559-6113
wburman@phs.org

University of New Mexico Cancer Center
Albuquerque 5454711, New Mexico 5481136 87106
Contact:
Site Public Contact
505-925-0348
HSC-ClinicalTrialInfo@salud.unm.edu

Albany Medical Center
Albany 5106834, New York 5128638 12208
Contact:
Site Public Contact
518-262-5513

Maimonides Medical Center
Brooklyn 5110302, New York 5128638 11219
Contact:
Site Public Contact
718-765-2500

Roswell Park Cancer Institute
Buffalo 5110629, New York 5128638 14263
Contact:
Site Public Contact
800-767-9355
askroswell@roswellpark.org

NYU Langone Hospital - Long Island
Mineola 5127134, New York 5128638 11501
Contact:
Site Public Contact
212-263-4432
cancertrials@nyulangone.org

The Steven and Alexandra Cohen Children's Medical Center of New York
New Hyde Park 5128514, New York 5128638 11040
Contact:
Site Public Contact
718-470-3460

Laura and Isaac Perlmutter Cancer Center at NYU Langone
New York 5128581, New York 5128638 10016
Contact:
Site Public Contact
CancerTrials@nyulangone.org

Mount Sinai Hospital
New York 5128581, New York 5128638 10029
Contact:
Site Public Contact
212-824-7309
CCTO@mssm.edu

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
New York 5128581, New York 5128638 10032
Contact:
Site Public Contact
212-342-5162
cancerclinicaltrials@cumc.columbia.edu

Memorial Sloan Kettering Cancer Center
New York 5128581, New York 5128638 10065
Contact:
Site Public Contact
212-639-7592

Stony Brook University Medical Center
Stony Brook 5139865, New York 5128638 11794
Contact:
Site Public Contact
800-862-2215

State University of New York Upstate Medical University
Syracuse 5140405, New York 5128638 13210
Contact:
Site Public Contact
315-464-5476

Montefiore Medical Center-Einstein Campus
The Bronx 5110266, New York 5128638 10461
Contact:
Site Public Contact
718-379-6866
eskwak@montefiore.org

Montefiore Medical Center-Weiler Hospital
The Bronx 5110266, New York 5128638 10461
Contact:
Site Public Contact
718-379-6866
eskwak@montefiore.org

Children's Hospital at Montefiore
The Bronx 5110266, New York 5128638 10467
Contact:
Site Public Contact
718-379-6866
aaraiza@montefiore.org

Montefiore Medical Center - Moses Campus
The Bronx 5110266, New York 5128638 10467
Contact:
Site Public Contact
718-379-6866
eskwak@montefiore.org

New York Medical College
Valhalla 5142090, New York 5128638 10595
Contact:
Site Public Contact
914-594-3794

Westchester Medical Center
Valhalla 5142090, New York 5128638 10595
Contact:
Site Public Contact
888-823-5923
ctsucontact@westat.com

Mission Hospital
Asheville 4453066, North Carolina 4482348 28801
Contact:
Site Public Contact
828-213-7055
NCDV.ResearchRegulatory@HCAHealthcare.com

UNC Lineberger Comprehensive Cancer Center
Chapel Hill 4460162, North Carolina 4482348 27599
Contact:
Site Public Contact
877-668-0683
cancerclinicaltrials@med.unc.edu

Carolinas Medical Center/Levine Cancer Institute
Charlotte 4460243, North Carolina 4482348 28203
Contact:
Site Public Contact
800-804-9376

Novant Health Presbyterian Medical Center
Charlotte 4460243, North Carolina 4482348 28204
Contact:
Site Public Contact
980-201-6360
kashah@novanthealth.org

Southeastern Medical Oncology Center-Clinton
Clinton 4461101, North Carolina 4482348 28328
Contact:
Site Public Contact
919-587-9084
jfields@cancersmoc.com

Duke University Medical Center
Durham 4464368, North Carolina 4482348 27710
Contact:
Site Public Contact
888-275-3853

Southeastern Medical Oncology Center-Goldsboro
Goldsboro 4468261, North Carolina 4482348 27534
Contact:
Site Public Contact
919-587-9084
jfields@cancersmoc.com

East Carolina University
Greenville 4469160, North Carolina 4482348 27834
Contact:
Site Public Contact
252-744-1015
eubankss@ecu.edu

Southeastern Medical Oncology Center-Jacksonville
Jacksonville 4473083, North Carolina 4482348 28546
Contact:
Site Public Contact
910-587-9084
jfields@cancersmoc.com

Wake Forest University Health Sciences
Winston-Salem 4499612, North Carolina 4482348 27157
Contact:
Site Public Contact
336-713-6771

Sanford Broadway Medical Center
Fargo 5059163, North Dakota 5690763 58122
Contact:
Site Public Contact
701-323-5760
OncologyClinicalTrialsFargo@sanfordhealth.org

Children's Hospital Medical Center of Akron
Akron 5145476, Ohio 5165418 44308
Contact:
Site Public Contact
330-543-3193

OhioHealth O'Bleness Hospital
Athens 4505542, Ohio 5165418 45701
Contact:
Site Public Contact
614-788-3860
Jennifer.Sexton@ohiohealth.com

Strecker Cancer Center-Belpre
Belpre 4506187, Ohio 5165418 45714
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

Adena Regional Medical Center
Chillicothe 4828890, Ohio 5165418 45601
Contact:
Site Public Contact
877-779-7585
Jeffh@columbusccop.org

Cincinnati Children's Hospital Medical Center
Cincinnati 4508722, Ohio 5165418 45229
Contact:
Site Public Contact
513-636-2799
cancer@cchmc.org

Case Western Reserve University
Cleveland 5150529, Ohio 5165418 44106
Contact:
Site Public Contact
800-641-2422
CTUReferral@UHhospitals.org

Rainbow Babies and Childrens Hospital
Cleveland 5150529, Ohio 5165418 44106
Contact:
Site Public Contact
216-844-5437

Cleveland Clinic Foundation
Cleveland 5150529, Ohio 5165418 44195
Contact:
Site Public Contact
866-223-8100
TaussigResearch@ccf.org

Nationwide Children's Hospital
Columbus 4509177, Ohio 5165418 43205
Contact:
Site Public Contact
614-722-6039
Melinda.Triplet@nationwidechildrens.org

Ohio State University Comprehensive Cancer Center
Columbus 4509177, Ohio 5165418 43210
Contact:
Site Public Contact
800-293-5066
Jamesline@osumc.edu

Mount Carmel East Hospital
Columbus 4509177, Ohio 5165418 43213
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

Columbus Oncology and Hematology Associates Inc
Columbus 4509177, Ohio 5165418 43214
Contact:
Site Public Contact
614-788-3860
Jennifer.Sexton@ohiohealth.com

Riverside Methodist Hospital
Columbus 4509177, Ohio 5165418 43214
Contact:
Site Public Contact
614-788-3860
Jennifer.Sexton@ohiohealth.com

Grant Medical Center
Columbus 4509177, Ohio 5165418 43215
Contact:
Site Public Contact
614-788-3860
Jennifer.Sexton@ohiohealth.com

The Mark H Zangmeister Center
Columbus 4509177, Ohio 5165418 43219
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

Mount Carmel Health Center West
Columbus 4509177, Ohio 5165418 43222
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

Doctors Hospital
Columbus 4509177, Ohio 5165418 43228
Contact:
Site Public Contact
614-788-3860
Jennifer.Sexton@ohiohealth.com

Dayton Children's Hospital
Dayton 4509884, Ohio 5165418 45404
Contact:
Site Public Contact
800-228-4055

Delaware Health Center-Grady Cancer Center
Delaware 5151891, Ohio 5165418 43015
Contact:
Site Public Contact
614-788-3860
Jennifer.Sexton@ohiohealth.com

Grady Memorial Hospital
Delaware 5151891, Ohio 5165418 43015
Contact:
Site Public Contact
614-788-3860
Jennifer.Sexton@ohiohealth.com

Columbus Oncology and Hematology Associates
Dublin 5152333, Ohio 5165418 43016
Contact:
Site Public Contact
614-788-3860
Jennifer.Sexton@ohiohealth.com

Dublin Methodist Hospital
Dublin 5152333, Ohio 5165418 43016
Contact:
Site Public Contact
614-788-3860
Jennifer.Sexton@ohiohealth.com

Mount Carmel Grove City Hospital
Grove City 4513409, Ohio 5165418 43123
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

Saint Rita's Medical Center
Lima 5160783, Ohio 5165418 45801
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

OhioHealth Mansfield Hospital
Mansfield 5161723, Ohio 5165418 44903
Contact:
Site Public Contact
614-788-3860
Jennifer.Sexton@ohiohealth.com

Marietta Memorial Hospital
Marietta 4517586, Ohio 5165418 45750
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

OhioHealth Marion General Hospital
Marion 5161902, Ohio 5165418 43302
Contact:
Site Public Contact
614-788-3860
Jennifer.Sexton@ohiohealth.com

Memorial Hospital
Marysville 5162077, Ohio 5165418 43040
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

Knox Community Hospital
Mount Vernon 5163799, Ohio 5165418 43050
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

Licking Memorial Hospital
Newark 5164466, Ohio 5165418 43055
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

Mercy Health - Perrysburg Hospital
Perrysburg 5166516, Ohio 5165418 43551
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

OhioHealth Pickerington Methodist Hospital
Pickerington 4521209, Ohio 5165418 43147
Contact:
Site Public Contact
614-788-3860
Jennifer.Sexton@ohiohealth.com

Southern Ohio Medical Center
Portsmouth 4521816, Ohio 5165418 45662
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

ProMedica Flower Hospital
Sylvania 5173572, Ohio 5165418 43560
Contact:
Site Public Contact
419-824-1842
PCIOncResearch@promedica.org

ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
Toledo 5174035, Ohio 5165418 43606
Contact:
Site Public Contact
419-824-1842
PCIOncResearch@promedica.org

Mercy Health - Saint Vincent Hospital
Toledo 5174035, Ohio 5165418 43608
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

Mercy Health - Saint Anne Hospital
Toledo 5174035, Ohio 5165418 43623
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

Saint Ann's Hospital
Westerville 5176472, Ohio 5165418 43081
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

OhioHealth Westerville Medical Campus/Westerville Cancer Center
Westerville 5176472, Ohio 5165418 43082
Contact:
Site Public Contact
610-788-3860
Jennifer.Sexton@ohiohealth.com

Clinton Memorial Hospital/Foster J Boyd Regional Cancer Center
Wilmington 4528463, Ohio 5165418 45177
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

Genesis Healthcare System Cancer Care Center
Zanesville 4528923, Ohio 5165418 43701
Contact:
Site Public Contact
614-488-2745
Jeffh@columbusccop.org

Cancer Centers of Southwest Oklahoma Research
Lawton 4540737, Oklahoma 4544379 73505
Contact:
Site Public Contact
877-231-4440

University of Oklahoma Health Sciences Center
Oklahoma City 4544349, Oklahoma 4544379 73104
Contact:
Site Public Contact
405-271-8777
ou-clinical-trials@ouhsc.edu

Saint Charles Health System
Bend 5713587, Oregon 5744337 97701
Contact:
Site Public Contact
541-706-2909
nosall@stcharleshealthcare.org

Clackamas Radiation Oncology Center
Clackamas 5719308, Oregon 5744337 97015
Contact:
Site Public Contact
503-215-2614
CanRsrchStudies@providence.org

Bay Area Hospital
Coos Bay 5720495, Oregon 5744337 97420
Contact:
Site Public Contact
541-269-8392
cherie.cox@bayareahospital.org

Providence Newberg Medical Center
Newberg 5742726, Oregon 5744337 97132
Contact:
Site Public Contact
503-215-2614
CanRsrchStudies@providence.org

Providence Willamette Falls Medical Center
Oregon City 5744253, Oregon 5744337 97045
Contact:
Site Public Contact
503-215-2614
CanRsrchStudies@providence.org

Providence Portland Medical Center
Portland 5746545, Oregon 5744337 97213
Contact:
Site Public Contact
503-215-2614
CanRsrchStudies@providence.org

Providence Saint Vincent Medical Center
Portland 5746545, Oregon 5744337 97225
Contact:
Site Public Contact
503-215-2614
CanRsrchStudies@providence.org

Legacy Emanuel Children's Hospital
Portland 5746545, Oregon 5744337 97227
Contact:
Site Public Contact
503-413-2560

Oregon Health and Science University
Portland 5746545, Oregon 5744337 97239
Contact:
Site Public Contact
503-494-1080
trials@ohsu.edu

Lehigh Valley Hospital-Cedar Crest
Allentown 5178127, Pennsylvania 6254927 18103
Contact:
Site Public Contact
610-402-9543
Morgan_M.Horton@lvhn.org

Geisinger Medical Center
Danville 5186327, Pennsylvania 6254927 17822
Contact:
Site Public Contact
570-271-5251
HemonCCTrials@geisinger.edu

Penn State Children's Hospital
Hershey 5193342, Pennsylvania 6254927 17033
Contact:
Site Public Contact
717-531-6012

Children's Hospital of Philadelphia
Philadelphia 4560349, Pennsylvania 6254927 19104
Contact:
Site Public Contact
267-425-5544
CancerTrials@email.chop.edu

University of Pennsylvania/Abramson Cancer Center
Philadelphia 4560349, Pennsylvania 6254927 19104
Contact:
Site Public Contact
855-216-0098
PennCancerTrials@careboxhealth.com

Saint Christopher's Hospital for Children
Philadelphia 4560349, Pennsylvania 6254927 19134
Contact:
Site Public Contact
215-427-8991

UPMC-Magee Womens Hospital
Pittsburgh 5206379, Pennsylvania 6254927 15213
Contact:
Site Public Contact
412-647-2811

Children's Hospital of Pittsburgh of UPMC
Pittsburgh 5206379, Pennsylvania 6254927 15224
Contact:
Site Public Contact
412-692-8570
jean.tersak@chp.edu

University of Pittsburgh Cancer Institute (UPCI)
Pittsburgh 5206379, Pennsylvania 6254927 15232
Contact:
Site Public Contact
412-647-8073

UPMC-Passavant Hospital
Pittsburgh 5206379, Pennsylvania 6254927 15237
Contact:
Site Public Contact
412-367-6454

Rhode Island Hospital
Providence 5224151, Rhode Island 5224323 02903
Contact:
Site Public Contact
401-444-1488

Prisma Health Cancer Institute - Spartanburg
Boiling Springs 4571805, South Carolina 4597040 29316
Contact:
Site Public Contact
864-522-4317
Kim.Williams3@prismahealth.org

Medical University of South Carolina
Charleston 4574324, South Carolina 4597040 29425
Contact:
Site Public Contact
843-792-9321
hcc-clinical-trials@musc.edu

Prisma Health Richland Hospital
Columbia 4575352, South Carolina 4597040 29203
Contact:
Site Public Contact
864-522-4317
Kim.Williams3@prismahealth.org

Gibbs Cancer Center-Gaffney
Gaffney 4579418, South Carolina 4597040 29341
Contact:
Site Public Contact
864-560-6104
kmertz-rivera@gibbscc.org

Saint Francis Hospital
Greenville 4580543, South Carolina 4597040 29601
Contact:
Site Public Contact
864-603-6234
Heather_Rich@bshsi.org

BI-LO Charities Children's Cancer Center
Greenville 4580543, South Carolina 4597040 29605
Contact:
Site Public Contact
864-522-4317
Kim.Williams3@prismahealth.org

Prisma Health Cancer Institute - Butternut
Greenville 4580543, South Carolina 4597040 29605
Contact:
Site Public Contact
864-522-4317
Kim.Williams3@prismahealth.org

Prisma Health Cancer Institute - Faris
Greenville 4580543, South Carolina 4597040 29605
Contact:
Site Public Contact
864-522-4317
Kim.Williams3@prismahealth.org

Saint Francis Cancer Center
Greenville 4580543, South Carolina 4597040 29607
Contact:
Site Public Contact
864-603-6234
Heather_Rich@bshsi.org

Prisma Health Cancer Institute - Eastside
Greenville 4580543, South Carolina 4597040 29615
Contact:
Site Public Contact
864-522-4317
Kim.Williams3@prismahealth.org

Prisma Health Cancer Institute - Greer
Greer 4580599, South Carolina 4597040 29650
Contact:
Site Public Contact
864-522-4317
Kim.Williams3@prismahealth.org

Gibbs Cancer Center-Pelham
Greer 4580599, South Carolina 4597040 29651
Contact:
Site Public Contact
864-560-6104
kmertz-rivera@gibbscc.org

Prisma Health Cancer Institute - Seneca
Seneca 4595346, South Carolina 4597040 29672
Contact:
Site Public Contact
864-522-4317
Kim.Williams3@prismahealth.org

North Grove Medical Park
Spartanburg 4597200, South Carolina 4597040 29303
Contact:
Site Public Contact
864-560-6812

Spartanburg Medical Center
Spartanburg 4597200, South Carolina 4597040 29303
Contact:
Site Public Contact
864-560-6104
kmertz-rivera@gibbscc.org

Spartanburg Medical Center - Mary Black Campus
Spartanburg 4597200, South Carolina 4597040 29307
Contact:
Site Public Contact
864-560-6812

SMC Center for Hematology Oncology Union
Union 4599214, South Carolina 4597040 29379
Contact:
Site Public Contact
864-560-6104
kmertz-rivera@gibbscc.org

Sanford USD Medical Center - Sioux Falls
Sioux Falls 5231851, South Dakota 5769223 57117-5134
Contact:
Site Public Contact
605-312-3320
OncologyClinicalTrialsSF@SanfordHealth.org

T C Thompson Children's Hospital
Chattanooga 4612862, Tennessee 4662168 37403
Contact:
Site Public Contact
423-778-7289

East Tennessee Childrens Hospital
Knoxville 4634946, Tennessee 4662168 37916
Contact:
Site Public Contact
865-541-8266

Saint Jude Children's Research Hospital
Memphis 4641239, Tennessee 4662168 38105
Contact:
Site Public Contact
888-226-4343
referralinfo@stjude.org

The Children's Hospital at TriStar Centennial
Nashville 4644585, Tennessee 4662168 37203
Contact:
Site Public Contact
615-342-1919

Vanderbilt University/Ingram Cancer Center
Nashville 4644585, Tennessee 4662168 37232
Contact:
Site Public Contact
800-811-8480

Texas Tech University Health Sciences Center-Amarillo
Amarillo 5516233, Texas 4736286 79106
Contact:
Site Public Contact
806-354-5411

Dell Children's Medical Center of Central Texas
Austin 4671654, Texas 4736286 78723
Contact:
Site Public Contact
512-628-1902
TXAUS-DL-SFCHemonc.research@ascension.org

Driscoll Children's Hospital
Corpus Christi 4683416, Texas 4736286 78411
Contact:
Site Public Contact
361-694-5311
Crystal.DeLosSantos@dchstx.org

Medical City Dallas Hospital
Dallas 4684888, Texas 4736286 75230
Contact:
Site Public Contact
972-566-5588

UT Southwestern/Simmons Cancer Center-Dallas
Dallas 4684888, Texas 4736286 75390
Contact:
Site Public Contact
214-648-7097
canceranswerline@UTSouthwestern.edu

El Paso Children's Hospital
El Paso 5520993, Texas 4736286 79905
Contact:
Site Public Contact
915-298-5444
ranjan.bista@ttuhsc.edu

Cook Children's Medical Center
Fort Worth 4691930, Texas 4736286 76104
Contact:
Site Public Contact
682-885-2103
CookChildrensResearch@cookchildrens.org

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
Houston 4699066, Texas 4736286 77030
Contact:
Site Public Contact
713-798-1354
burton@bcm.edu

M D Anderson Cancer Center
Houston 4699066, Texas 4736286 77030
Contact:
Site Public Contact
877-632-6789
askmdanderson@mdanderson.org

Covenant Children's Hospital
Lubbock 5525577, Texas 4736286 79410
Contact:
Site Public Contact
806-725-8657
mbisbee@providence.org

UMC Cancer Center / UMC Health System
Lubbock 5525577, Texas 4736286 79415
Contact:
Site Public Contact
806-775-8590

Children's Hospital of San Antonio
San Antonio 4726206, Texas 4736286 78207
Contact:
Site Public Contact
210-704-2894
bridget.medina@christushealth.org

Methodist Children's Hospital of South Texas
San Antonio 4726206, Texas 4736286 78229
Contact:
Site Public Contact
210-575-6240
Vinod.GidvaniDiaz@hcahealthcare.com

University Hospital
San Antonio 4726206, Texas 4736286 78229
Contact:
Site Public Contact
210-358-4176
evelyn.swenson-britt@uhs-sa.com

University of Texas Health Science Center at San Antonio
San Antonio 4726206, Texas 4736286 78229
Contact:
Site Public Contact
210-450-3800
phoresearchoffice@uthscsa.edu

Scott and White Memorial Hospital
Temple 4735966, Texas 4736286 76508
Contact:
Site Public Contact
254-724-5407

Primary Children's Hospital
Salt Lake City 5780993, Utah 5549030 84113
Contact:
Site Public Contact
801-585-5270

University of Vermont and State Agricultural College
Burlington 5234372, Vermont 5242283 05405
Contact:
Site Public Contact
802-656-8990
rpo@uvm.edu

University of Virginia Cancer Center
Charlottesville 4752031, Virginia 6254928 22908
Contact:
Site Public Contact
434-243-6303
uvacancertrials@hscmail.mcc.virginia.edu

Children's Hospital of The King's Daughters
Norfolk 4776222, Virginia 6254928 23507
Contact:
Site Public Contact
757-668-7243
CCBDCresearch@chkd.org

Naval Medical Center - Portsmouth
Portsmouth 4779999, Virginia 6254928 23708-2197
Contact:
Site Public Contact
757-953-5939

VCU Massey Comprehensive Cancer Center
Richmond 4781708, Virginia 6254928 23298
Contact:
Site Public Contact
804-628-6430
CTOclinops@vcu.edu

Carilion Children's
Roanoke 4782167, Virginia 6254928 24014
Contact:
Site Public Contact
540-266-6238
wpmccarty@carilionclinic.org

Providence Regional Cancer System-Aberdeen
Aberdeen 5785243, Washington 5815135 98520
Contact:
Site Public Contact
360-412-8958
deidre.dillon@providence.org

PeaceHealth Saint Joseph Medical Center
Bellingham 5786899, Washington 5815135 98225
Contact:
Site Public Contact
360-788-8223

Providence Regional Cancer System-Centralia
Centralia 5789683, Washington 5815135 98531
Contact:
Site Public Contact
360-412-8958
deidre.dillon@providence.org

Swedish Cancer Institute-Edmonds
Edmonds 5793427, Washington 5815135 98026
Contact:
Site Public Contact
206-215-2343
PCRC-NCORP@Swedish.org

Providence Regional Cancer Partnership
Everett 5793933, Washington 5815135 98201
Contact:
Site Public Contact
425-261-3529
marilyn.birchman@providence.org

Swedish Cancer Institute-Issaquah
Issaquah 5798487, Washington 5815135 98029
Contact:
Site Public Contact
206-215-2343
PCRC-NCORP@Swedish.org

Kadlec Clinic Hematology and Oncology
Kennewick 5799610, Washington 5815135 99336
Contact:
Site Public Contact
509-783-4637
research@kadlecmed.org

Providence Regional Cancer System-Lacey
Lacey 5800112, Washington 5815135 98503
Contact:
Site Public Contact
360-412-8958
deidre.dillon@providence.org

PeaceHealth Saint John Medical Center
Longview 5801617, Washington 5815135 98632
Contact:
Site Public Contact
360-514-2016
kmakin-bond@peacehealth.org

Seattle Children's Hospital
Seattle 5809844, Washington 5815135 98105
Contact:
Site Public Contact
866-987-2000

Swedish Medical Center-Ballard Campus
Seattle 5809844, Washington 5815135 98107
Contact:
Site Public Contact
206-215-3086
PCRC-NCORP@Swedish.org

Swedish Medical Center-Cherry Hill
Seattle 5809844, Washington 5815135 98122-5711
Contact:
Site Public Contact
206-215-3086
PCRC-NCORP@Swedish.org

Swedish Medical Center-First Hill
Seattle 5809844, Washington 5815135 98122
Contact:
Site Public Contact
206-215-2343
PCRC-NCORP@Swedish.org

Providence Sacred Heart Medical Center and Children's Hospital
Spokane 5811696, Washington 5815135 99204
Contact:
Site Public Contact
800-228-6618
HopeBeginsHere@providence.org

Mary Bridge Children's Hospital and Health Center
Tacoma 5812944, Washington 5815135 98405
Contact:
Site Public Contact
253-403-1461
research@multicare.org

Madigan Army Medical Center
Tacoma 5812944, Washington 5815135 98431
Contact:
Site Public Contact
253-968-6144
melissa.a.forouhar.mil@health.mil

Providence Saint Mary Regional Cancer Center
Walla Walla 5814916, Washington 5815135 99362
Contact:
Site Public Contact
509-897-5993
Cheryl.Dodd@providence.org

North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
Yakima 5816605, Washington 5815135 98902
Contact:
Site Public Contact
509-574-3535
Memorial-ClinicalTrials@yvmh.org

West Virginia University Charleston Division
Charleston 4801859, West Virginia 4826850 25304
Contact:
Site Public Contact
304-388-9944

Edwards Comprehensive Cancer Center
Huntington 4809537, West Virginia 4826850 25701
Contact:
Site Public Contact
304-399-6566
Christina.Cole@chhi.org

West Virginia University Healthcare
Morgantown 4815352, West Virginia 4826850 26506
Contact:
Site Public Contact
304-293-7374
cancertrialsinfo@hsc.wvu.edu

Green Bay Oncology at Saint Vincent Hospital
Green Bay 5254962, Wisconsin 5279468 54301-3526
Contact:
John R. Hill
920-433-8889
Christy.Gilchrist@hshs.org

Saint Vincent Hospital Cancer Center Green Bay
Green Bay 5254962, Wisconsin 5279468 54301
Contact:
Site Public Contact
920-433-8889
WI_research_admin@hshs.org

Saint Vincent Hospital Cancer Center at Saint Mary's
Green Bay 5254962, Wisconsin 5279468 54303
Contact:
Site Public Contact
920-433-8889
wi_research_admin@hshs.org

University of Wisconsin Carbone Cancer Center - University Hospital
Madison 5261457, Wisconsin 5279468 53792
Contact:
Site Public Contact
800-622-8922
clinicaltrials@cancer.wisc.edu

Children's Hospital of Wisconsin
Milwaukee 5263045, Wisconsin 5279468 53226
Contact:
Site Public Contact
414-955-4727
MACCCTO@mcw.edu

Saint Vincent Hospital Cancer Center at Oconto Falls
Oconto Falls 5265522, Wisconsin 5279468 54154
Contact:
Site Public Contact
920-433-8889
WI_research_admin@hshs.org

HSHS Saint Nicholas Hospital
Sheboygan 5272893, Wisconsin 5279468 53081
Contact:
Site Public Contact
920-433-8889
ewd_research_admin@hshs.org

Saint Vincent Hospital Cancer Center at Sturgeon Bay
Sturgeon Bay 5274867, Wisconsin 5279468 54235-1495
Contact:
Site Public Contact
920-433-8889
wi_research_admin@hshs.org

More Details

NCT ID
NCT03067181
Status
Recruiting
Sponsor
Children's Oncology Group

Detailed Description

PRIMARY OBJECTIVES: I. To evaluate whether a strategy of complete surgical resection followed by surveillance can maintain an overall survival rate of at least 95.7% at two years for pediatric, adolescent and adult patients with stage I (low risk) malignant germ cell tumors (Stratum 2), and at least 88% for patients with all stage/grade ovarian pure immature teratoma (Stratum 1). II. To compare the event-free survival of a carboplatin versus (vs.) cisplatin-based regimen in the treatment of pediatric, adolescent and young adult patients with standard risk non-seminomatous germ cell tumors. IIa. To compare the event free survival (EFS) of a carboplatin-based regimen (carboplatin [C] etoposide [E] bleomycin [b]) vs. a cisplatin-based regimen (cisplatin [P]Eb) in children (less than 11 years in age) with standard risk germ cell tumors (GCT). IIb. To compare the EFS of a carboplatin-based regimen (BEC) vs. a cisplatin-based regimen (BEP) in adolescents and young adults (ages 11 - < 25 years) with standard risk GCT. SECONDARY OBJECTIVES: I. To compare the incidence of ototoxicity in children, adolescents and young adults with standard risk germ cell tumors treated with carboplatin-based chemotherapy as compared to cisplatin-based chemotherapy. II. To refine and validate a novel patient-reported measure of hearing outcomes for children, adolescents and young adults with standard risk germ cell tumors. III. To determine whether radiomic measures of body composition at diagnosis, end of therapy, and one year after end of therapy is better correlated with adverse events compared to body surface area in patients receiving chemotherapy for germ cell tumors. EXPLORATORY OBJECTIVES: I. To prospectively determine the correlation of tumor marker decline (alpha-fetoprotein [FP] and beta-human chorionic gonadotropin [HCG]) with clinical outcome in low and standard risk germ cell tumor patients. II. To compare self-reported peripheral neuropathy and other patient-reported outcomes between children, adolescents and young adults with standard risk germ cell tumors treated with carboplatin-based chemotherapy as compared to cisplatin-based chemotherapy. III. Assess the relationship between hearing loss as measured by audiometry with the effects of tinnitus as assessed on the Adolescent and Young Adult Hearing Screening (AYA-HEARS) instrument. IV. To evaluate the prognostic significance of serum micro ribonucleic acid (miRNA)s in stage I testicular cancer (seminoma and non-seminoma) patients by collecting clinical data and serum specimens for future analysis. V. To compare differences in the proportion of patients with residual mass(es) ≥ 1 cm at the completion of chemotherapy among patients randomized to the cisplatin and carboplatin-containing arms and to compare the proportion undergoing post-chemotherapy surgery for residual mass(es), and the proportion of resected masses with viable malignancy, teratoma, or necrosis. OUTLINE: Patients with low-risk stage I grade 2, 3 ovarian immature teratoma or stage I non-seminoma malignant germ cell tumors (MGCT)s undergo observation and can transfer to standard risk arm at time of recurrence if eligibility criteria are met. Patients with stage I seminoma testicular MGCT undergo observation, and those with residual/recurrent disease are treated at the discretion of their physician. Patients undergo computed tomography (CT), magnetic resonance imaging (MRI), and/or chest x-ray as well as blood sample collection throughout the trial to monitor for response and recurrence. Patients may also undergo a tumor biopsy throughout the trial. Patients with standard risk 1 are randomized into 1 of 2 arms. ARM I (CEb): Patients receive bleomycin intravenously (IV) over 10 minutes and carboplatin IV over 1 hour on day 1. Patients also receive etoposide IV over 1-2 hours on days 1-5. Treatment repeats every 21 days for up to 4 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT, MRI, and/or chest x-ray as well as blood sample collection throughout the trial. Patients may also undergo a tumor biopsy throughout the trial. Patients undergo a pulmonary function test on study. ARM II (PEb): Patients receive bleomycin IV over 10 minutes on day 1. Patients also receive etoposide IV over 1-2 hours and cisplatin IV over 1-3 hours on days 1-5. Treatment repeats every 21 days for up to 4 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT, MRI, and/or chest x-ray as well as blood sample collection throughout the trial. Patients may also undergo a tumor biopsy throughout the trial. Patients undergo a pulmonary function test on study. Patients with standard risk 2 are randomized into 1 of 2 arms. ARM III (BEC): Patients receive bleomycin IV over 10 minutes on days 1, 8, and 15, etoposide IV over 1-2 hours on days 1-5, and carboplatin IV over 1 hour on day 1. Treatment repeats every 21 days for up to 3 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT, MRI, and/or chest x-ray as well as blood sample collection throughout the trial. Patients may also undergo a tumor biopsy throughout the trial. Patients undergo a pulmonary function test on study. ARM IV (BEP): Patients receive bleomycin IV over 10 minutes on days 1, 8, and 15, etoposide IV over 1-2 hours on days 1-5, and cisplatin IV over 1-3 hours on days 1-5. Treatment repeats every 21 days for up to 3 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT, MRI, and/or chest x-ray as well as blood sample collection throughout the trial. Patients may also undergo a tumor biopsy throughout the trial. Patients undergo a pulmonary function test on study. After completion of study treatment, patients are followed up every 2 months for 12 months, every 3-6 months to 24 months, every 6 months for years 3-5, and then annually for up to 10 years.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.